Inventor
CHEEVER MARTIN A
US27 patents
⚠️ This page may combine multiple inventors who share the name “CHEEVER MARTIN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV WASHINGTON
14 patentsUS5876712AMar 2, 1999
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
UNIV WASHINGTON127 citations99
US5869445AFeb 9, 1999
Methods for eliciting or enhancing reactivity to HER-2/neu protein
UNIV WASHINGTON287 citations99
US5846538ADec 8, 1998
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
UNIV WASHINGTON122 citations99
US5801005ASep 1, 1998
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
UNIV WASHINGTON296 citations99
US5726023AMar 10, 1998
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
UNIV WASHINGTON181 citations99
US7063854B1Jun 20, 2006
Composition and methods for WTI specific immunotherapy
UNIV WASHINGTON59 citations96
US6664370B2Dec 16, 2003
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
UNIV WASHINGTON35 citations96
US6075122AJun 13, 2000
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
UNIV WASHINGTON36 citations96
US7115272B1Oct 3, 2006
Compositions and methods for WT1 specific immunotherapy
UNIV WASHINGTON35 citations92
US7247703B2Jul 24, 2007
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
UNIV WASHINGTON7 citations74
US6953573B1Oct 11, 2005
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
UNIV WASHINGTON8 citations74
US6942862B2Sep 13, 2005
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
UNIV WASHINGTON7 citations74
US7655239B2Feb 2, 2010
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
UNIV WASHINGTON2 citations63
US7601697B2Oct 13, 2009
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
UNIV WASHINGTON0 citations52
CORIXA CORP
8 patentsUS7662386B2Feb 16, 2010
Compositions and methods for WT1 specific immunotherapy
CORIXA CORP16 citations92
US7329410B1Feb 12, 2008
Compositions and method for WT1 specific immunotherapy
CORIXA CORP17 citations92
US7144581B2Dec 5, 2006
Compositions and methods for WT1 specific immunotherapy
CORIXA CORP35 citations92
US7375091B2May 20, 2008
HER-2/neu fusion proteins
CORIXA CORP14 citations90
US7901693B2Mar 8, 2011
Compositions and methods for WT1 specific immunotherapy
CORIXA CORP11 citations84
US7368119B2May 6, 2008
Compositions and methods for WT1 specific immunotherapy
CORIXA CORP13 citations84
US7229623B1Jun 12, 2007
Her-2/neu fusion proteins
CORIXA CORP14 citations82
US7198920B1Apr 3, 2007
HER-2/neu fusion proteins
CORIXA CORP8 citations71
WASHINGTON RES FOUND
3 patentsUS5601989AFeb 11, 1997
Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
WASHINGTON RES FOUND23 citations91
US5320947AJun 14, 1994
Immune reactivity to expressed activated oncogenes for diagnosis of malignancy
WASHINGTON RES FOUND28 citations91
US5773230AJun 30, 1998
Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
WASHINGTON RES FOUND11 citations72